NCT01361945: AUY922 With Lapatinib and Letrozole for ER+ HER2+ Advanced Breast Cancer |
|
|
| Withdrawn | 1/2 | 0 | NA | AUY922, Intravenous drug | Texas Tech University Health Sciences Center, El Paso | Breast Cancer, Metastatic Breast Cancer, HER-2 Positive Breast Cancer, ER Positive Breast Cancer | 08/12 | 08/12 | | |
